hunter biodiscovery
Hunter Biodiscovery speeds the discovery of effective cancer drug combinations. It uses an ultra-high throughput microfluidics platform to test many drug pairs on live cells. The core technologies are microfluidics, chemistry, and machine learning to identify synergistic pairs and move them toward validation. The company provides R&D services and partnerships with biotechnology and pharmaceutical firms. Typical customers are biotech and pharma companies seeking faster preclinical insights.
hunter biodiscovery
Hunter Biodiscovery speeds the discovery of effective cancer drug combinations. It uses an ultra-high throughput microfluidics platform to test many drug pairs on live cells. The core technologies are microfluidics, chemistry, and machine learning to identify synergistic pairs and move them toward validation. The company provides R&D services and partnerships with biotechnology and pharmaceutical firms. Typical customers are biotech and pharma companies seeking faster preclinical insights.